LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$131M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$123M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$119M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$115M |
Top Sells
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$65M |
| 2 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$42.6M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$38.4M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$35.5M |
| 5 |
Vanguard S&P 500 Value ETF
VOOV
|
+$26.6M |
Sector Composition
| 1 | Technology | 3.1% |
| 2 | Financials | 2.91% |
| 3 | Industrials | 2.38% |
| 4 | Healthcare | 2.26% |
| 5 | Communication Services | 2.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Broadridge
BR
$29.5B
| $1.44M | ﹤0.01% |
13,143
+8,290
| +171% | +$910K |
|
1327
Best Buy
BBY
$15.9B
| $1.44M | ﹤0.01% |
20,578
+5,104
| +33% | +$357K |
|
|
TIF
1328
DELISTED
Tiffany & Co.
TIF
| $1.44M | ﹤0.01% |
14,749
+1,665
| +13% | +$163K |
|
|
MOMO
1329
Hello Group
MOMO
$1.19B
| $1.44M | ﹤0.01% |
38,477
+10,539
| +38% | +$394K |
|
|
IBDC
1330
DELISTED
iShares iBonds Mar 2020 Term Corporate ETF
IBDC
| $1.44M | ﹤0.01% |
55,383
+34,400
| +164% | +$891K |
|
1331
Invesco DB US Dollar Index Bullish Fund
UUP
$162M
| $1.43M | ﹤0.01% |
60,717
-8,517
| -12% | -$201K |
|
1332
abrdn Physical Gold Shares ETF
SGOL
$5.8B
| $1.43M | ﹤0.01% |
111,690
+6,480
| +6% | +$83.1K |
|
1333
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$404M
| $1.43M | ﹤0.01% |
54,301
+6,306
| +13% | +$166K |
|
1334
Gladstone Investment Corp
GAIN
$544M
| $1.43M | ﹤0.01% |
141,409
+72,060
| +104% | +$728K |
|
|
HPF
1335
John Hancock Preferred Income Fund II
HPF
$357M
| $1.43M | ﹤0.01% |
71,216
+41,731
| +142% | +$837K |
|
1336
Ameriprise Financial
AMP
$46.9B
| $1.43M | ﹤0.01% |
9,638
-1,612
| -14% | -$239K |
|
1337
Ovintiv
OVV
$10.8B
| $1.43M | ﹤0.01% |
25,924
-607
| -2% | -$33.4K |
|
1338
DB Gold Short ETN due February 15, 2038
DGZ
$2.04M
| $1.42M | ﹤0.01% |
105,019
+5,188
| +5% | +$70.3K |
|
1339
Carlyle Group
CG
$24.1B
| $1.42M | ﹤0.01% |
66,609
+4,492
| +7% | +$95.9K |
|
1340
iShares MSCI ACWI ex US ETF
ACWX
$6.79B
| $1.42M | ﹤0.01% |
28,551
-181,598
| -86% | -$9.03M |
|
1341
Dolby
DLB
$6.85B
| $1.42M | ﹤0.01% |
22,312
-3,093
| -12% | -$197K |
|
1342
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
$37.2M
| $1.42M | ﹤0.01% |
41,930
+35,879
| +593% | +$1.21M |
|
|
SRCL
1343
DELISTED
Stericycle Inc
SRCL
| $1.42M | ﹤0.01% |
24,180
+1
| +0% | +$59 |
|
1344
West Pharmaceutical
WST
$18.2B
| $1.41M | ﹤0.01% |
16,043
+2,185
| +16% | +$192K |
|
1345
Post Holdings
POST
$5.7B
| $1.41M | ﹤0.01% |
28,398
+11,543
| +68% | +$572K |
|
1346
SPDR Portfolio TIPS ETF
SPIP
$988M
| $1.41M | ﹤0.01% |
50,464
+2,478
| +5% | +$69.1K |
|
1347
Service Corp International
SCI
$11.2B
| $1.41M | ﹤0.01% |
37,261
-13,385
| -26% | -$505K |
|
1348
Travel + Leisure Co
TNL
$4.02B
| $1.4M | ﹤0.01% |
27,167
+1,714
| +7% | +$88.5K |
|
|
GGT
1349
Gabelli Multimedia Trust
GGT
$156M
| $1.39M | ﹤0.01% |
152,638
+2,980
| +2% | +$27.2K |
|
|
TVRD
1350
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $1.39M | ﹤0.01% |
3,127
+1,065
| +52% | +$475K |
|